Publication | Closed Access

Administration of SB239063, a potent p38 MAPK inhibitor, alleviates acute lung injury induced by intestinal ischemia reperfusion in rats associated with AQP4 downregulation

Acute Lung InjuryInflammationMolecular PharmacologyAnti-inflammatoryLung InflammationMedicineImmunologyPulmonary PharmacologyIntestinal Ischemia ReperfusionPharmacotherapyPharmacologyAqp4 Downregulation